+ Watch ANGO
on My Watchlist
The Company is a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease and local oncology therapy options for treating cancer.
Insiders have bought on the open market for $11.8 this year. and have bought more than 5 times as many shares as they've sold in that period.
I can see this going to $37. Not the world's safest bet, but having been in the red very recently may be the reason it's still undervalued. Some risks are worth taking for stocks like this.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions